Global AI-Designed Small-Molecule Drugs Market Growth 2026-2032
The global AI-Designed Small-Molecule Drugs market size is predicted to grow from US$ 1256 million in 2025 to US$ 6143 million in 2032; it is expected to grow at a CAGR of 25.7% from 2026 to 2032.
AI-designed small-molecule drugs are synthesizable and developable drug candidates for which machine learning, generative AI, and physics-based modeling make a material contribution to target identification, virtual screening, molecular generation, structure–activity optimization, or ADMET prediction. They are supplied as discovery-stage molecules, preclinical candidates, clinical pipeline assets, or licensed programs and are evaluated by target novelty, potency and selectivity, oral exposure, tissue distribution, safety margin, manufacturability, and intellectual property. Major uses include oncology, immunology and inflammation, neurology, metabolic disease, and infectious disease research. The market scope covers related R&D spending, collaboration revenue, upfront licensing payments, and milestone value rather than end-market prescription drug sales, with an estimated blended gross margin of about 68%.
Demand is driven by pharmaceutical companies seeking to shorten early discovery cycles, expand the range of druggable targets, and improve the quality of candidates entering clinical development. Oncology, immunology and inflammation, neurology, and metabolic diseases are the first areas to build dense AI-enabled pipelines because they combine substantial unmet need with increasingly rich target and molecular data. Demand is particularly strong for oral therapies, brain-penetrant compounds, mutation-selective inhibitors, and programs against historically difficult targets.
Competition is moving beyond stand-alone virtual screening toward closed loops that connect target discovery, generative design, automated synthesis, experimental validation, and clinical translation. Leading suppliers are building proprietary datasets, physics-based simulation, foundation models, and wet-lab infrastructure while validating their systems through internal pipelines and pharmaceutical partnerships. Product development is advancing toward simultaneous multiparameter optimization, more reliable selectivity and toxicity prediction, protein dynamics modeling, active learning, and exploration of new chemical space for protein degradation and nucleic-acid targets.
North America continues to concentrate most AI-native drug developers, capital, and large-pharma partnerships, while the United Kingdom, France, and China are building differentiated capabilities in generative chemistry, structure prediction, laboratory automation, and clinical execution. Customers increasingly evaluate suppliers by delivered candidates, clinical milestones, data feedback loops, and intellectual-property boundaries rather than model benchmarks alone. Key risks include long clinical validation cycles, biased training data, limited synthetic feasibility, and complex ownership of partnered assets. Companies with end-to-end development capability, repeatable delivery records, and cross-regional clinical resources are better positioned to secure licensing and co-development opportunities.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “AI-Designed Small-Molecule Drugs Industry Forecast” looks at past sales and reviews total world AI-Designed Small-Molecule Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected AI-Designed Small-Molecule Drugs sales for 2026 through 2032. With AI-Designed Small-Molecule Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-Designed Small-Molecule Drugs industry.
This Insight Report provides a comprehensive analysis of the global AI-Designed Small-Molecule Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI-Designed Small-Molecule Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-Designed Small-Molecule Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-Designed Small-Molecule Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-Designed Small-Molecule Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-Designed Small-Molecule Drugs market by product type, application, key manufacturers and key regions and countries.
AI-designed small-molecule drugs are synthesizable and developable drug candidates for which machine learning, generative AI, and physics-based modeling make a material contribution to target identification, virtual screening, molecular generation, structure–activity optimization, or ADMET prediction. They are supplied as discovery-stage molecules, preclinical candidates, clinical pipeline assets, or licensed programs and are evaluated by target novelty, potency and selectivity, oral exposure, tissue distribution, safety margin, manufacturability, and intellectual property. Major uses include oncology, immunology and inflammation, neurology, metabolic disease, and infectious disease research. The market scope covers related R&D spending, collaboration revenue, upfront licensing payments, and milestone value rather than end-market prescription drug sales, with an estimated blended gross margin of about 68%.
Demand is driven by pharmaceutical companies seeking to shorten early discovery cycles, expand the range of druggable targets, and improve the quality of candidates entering clinical development. Oncology, immunology and inflammation, neurology, and metabolic diseases are the first areas to build dense AI-enabled pipelines because they combine substantial unmet need with increasingly rich target and molecular data. Demand is particularly strong for oral therapies, brain-penetrant compounds, mutation-selective inhibitors, and programs against historically difficult targets.
Competition is moving beyond stand-alone virtual screening toward closed loops that connect target discovery, generative design, automated synthesis, experimental validation, and clinical translation. Leading suppliers are building proprietary datasets, physics-based simulation, foundation models, and wet-lab infrastructure while validating their systems through internal pipelines and pharmaceutical partnerships. Product development is advancing toward simultaneous multiparameter optimization, more reliable selectivity and toxicity prediction, protein dynamics modeling, active learning, and exploration of new chemical space for protein degradation and nucleic-acid targets.
North America continues to concentrate most AI-native drug developers, capital, and large-pharma partnerships, while the United Kingdom, France, and China are building differentiated capabilities in generative chemistry, structure prediction, laboratory automation, and clinical execution. Customers increasingly evaluate suppliers by delivered candidates, clinical milestones, data feedback loops, and intellectual-property boundaries rather than model benchmarks alone. Key risks include long clinical validation cycles, biased training data, limited synthetic feasibility, and complex ownership of partnered assets. Companies with end-to-end development capability, repeatable delivery records, and cross-regional clinical resources are better positioned to secure licensing and co-development opportunities.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “AI-Designed Small-Molecule Drugs Industry Forecast” looks at past sales and reviews total world AI-Designed Small-Molecule Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected AI-Designed Small-Molecule Drugs sales for 2026 through 2032. With AI-Designed Small-Molecule Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-Designed Small-Molecule Drugs industry.
This Insight Report provides a comprehensive analysis of the global AI-Designed Small-Molecule Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI-Designed Small-Molecule Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-Designed Small-Molecule Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-Designed Small-Molecule Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-Designed Small-Molecule Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-Designed Small-Molecule Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Discovery-Stage Candidates
- Preclinical Candidates
- Clinical-Stage Candidates
- Approved Drugs
Segmentation by Mechanism of Action:
- Enzyme Inhibitors
- Receptor Agonists
- Receptor Antagonists
- Targeted Protein Degraders
- Molecular Glues
- Other Small-Molecule Modulators
Segmentation by Route of Administration:
- Oral Drugs
- Injectable Drugs
- Inhaled Drugs
- Topical Drugs
- Other Administration Routes
Segmentation by Target Class:
- Kinases
- Other Enzymes
- G Protein-Coupled Receptors
- Nuclear Receptors
- Protein–Protein Interaction Targets
- Nucleic Acid Targets
- Other Target Classes
Segmentation by Application:
- Oncology
- Immunology and Inflammation
- Neurology and Psychiatry
- Metabolic and Cardiovascular Diseases
- Infectious Diseases
- Other Therapeutic Areas
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Recursion Pharmaceuticals
- Insilico Medicine
- Schr?dinger
- XtalPi
- Isomorphic Labs
- Relay Therapeutics
- Nimbus Therapeutics
- Iambic Therapeutics
- BenevolentAI
- Accutar Biotechnology
- MindRank AI
- Enveda Biosciences
- Insitro
- Valo Health
- Healx
- Lantern Pharma
- Verge Labs
- DeepCure
- AQEMIA
- Genesis Molecular AI
- Terray Therapeutics
- CHARM Therapeutics
- Anagenex
- StoneWise
Key Questions Addressed in this Report
- What is the 10-year outlook for the global AI-Designed Small-Molecule Drugs market?
- What factors are driving AI-Designed Small-Molecule Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do AI-Designed Small-Molecule Drugs market opportunities vary by end market size?
- How does AI-Designed Small-Molecule Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI-Designed Small-Molecule Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for AI-Designed Small-Molecule Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for AI-Designed Small-Molecule Drugs by Country/Region, 2021, 2025 & 2032
2.2 AI-Designed Small-Molecule Drugs Segment by Type
2.2.1 Discovery-Stage Candidates
2.2.2 Preclinical Candidates
2.2.3 Clinical-Stage Candidates
2.2.4 Approved Drugs
2.2.5 AI-Designed Small-Molecule Drugs Sales by Type
2.2.5.1 Global AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global AI-Designed Small-Molecule Drugs Sale Price by Type (2021-2026)
2.3 AI-Designed Small-Molecule Drugs Segment by Mechanism of Action
2.3.1 Enzyme Inhibitors
2.3.2 Receptor Agonists
2.3.3 Receptor Antagonists
2.3.4 Targeted Protein Degraders
2.3.5 Molecular Glues
2.3.6 Other Small-Molecule Modulators
2.3.7 AI-Designed Small-Molecule Drugs Sales by Mechanism of Action
2.3.7.1 Global AI-Designed Small-Molecule Drugs Sales Market Share by Mechanism of Action (2021-2026)
2.3.7.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Mechanism of Action (2021-2026)
2.3.7.3 Global AI-Designed Small-Molecule Drugs Sale Price by Mechanism of Action (2021-2026)
2.4 AI-Designed Small-Molecule Drugs Segment by Route of Administration
2.4.1 Oral Drugs
2.4.2 Injectable Drugs
2.4.3 Inhaled Drugs
2.4.4 Topical Drugs
2.4.5 Other Administration Routes
2.4.6 AI-Designed Small-Molecule Drugs Sales by Route of Administration
2.4.6.1 Global AI-Designed Small-Molecule Drugs Sales Market Share by Route of Administration (2021-2026)
2.4.6.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Route of Administration (2021-2026)
2.4.6.3 Global AI-Designed Small-Molecule Drugs Sale Price by Route of Administration (2021-2026)
2.5 AI-Designed Small-Molecule Drugs Segment by Target Class
2.5.1 Kinases
2.5.2 Other Enzymes
2.5.3 G Protein-Coupled Receptors
2.5.4 Nuclear Receptors
2.5.5 Protein–Protein Interaction Targets
2.5.6 Nucleic Acid Targets
2.5.7 Other Target Classes
2.5.8 AI-Designed Small-Molecule Drugs Sales by Target Class
2.5.8.1 Global AI-Designed Small-Molecule Drugs Sales Market Share by Target Class (2021-2026)
2.5.8.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Target Class (2021-2026)
2.5.8.3 Global AI-Designed Small-Molecule Drugs Sale Price by Target Class (2021-2026)
2.6 AI-Designed Small-Molecule Drugs Segment by Application
2.6.1 Oncology
2.6.2 Immunology and Inflammation
2.6.3 Neurology and Psychiatry
2.6.4 Metabolic and Cardiovascular Diseases
2.6.5 Infectious Diseases
2.6.6 Other Therapeutic Areas
2.6.7 AI-Designed Small-Molecule Drugs Sales by Application
2.6.7.1 Global AI-Designed Small-Molecule Drugs Sale Market Share by Application (2021-2026)
2.6.7.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Application (2021-2026)
2.6.7.3 Global AI-Designed Small-Molecule Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global AI-Designed Small-Molecule Drugs Breakdown Data by Company
3.1.1 Global AI-Designed Small-Molecule Drugs Annual Sales by Company (2021-2026)
3.1.2 Global AI-Designed Small-Molecule Drugs Sales Market Share by Company (2021-2026)
3.2 Global AI-Designed Small-Molecule Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global AI-Designed Small-Molecule Drugs Revenue by Company (2021-2026)
3.2.2 Global AI-Designed Small-Molecule Drugs Revenue Market Share by Company (2021-2026)
3.3 Global AI-Designed Small-Molecule Drugs Sale Price by Company
3.4 Key Manufacturers AI-Designed Small-Molecule Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers AI-Designed Small-Molecule Drugs Product Location Distribution
3.4.2 Players AI-Designed Small-Molecule Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AI-DESIGNED SMALL-MOLECULE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic AI-Designed Small-Molecule Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global AI-Designed Small-Molecule Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global AI-Designed Small-Molecule Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic AI-Designed Small-Molecule Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global AI-Designed Small-Molecule Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global AI-Designed Small-Molecule Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI-Designed Small-Molecule Drugs Sales Growth
4.4 APAC AI-Designed Small-Molecule Drugs Sales Growth
4.5 Europe AI-Designed Small-Molecule Drugs Sales Growth
4.6 Middle East & Africa AI-Designed Small-Molecule Drugs Sales Growth
5 AMERICAS
5.1 Americas AI-Designed Small-Molecule Drugs Sales by Country
5.1.1 Americas AI-Designed Small-Molecule Drugs Sales by Country (2021-2026)
5.1.2 Americas AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026)
5.2 Americas AI-Designed Small-Molecule Drugs Sales by Type (2021-2026)
5.3 Americas AI-Designed Small-Molecule Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-Designed Small-Molecule Drugs Sales by Region
6.1.1 APAC AI-Designed Small-Molecule Drugs Sales by Region (2021-2026)
6.1.2 APAC AI-Designed Small-Molecule Drugs Revenue by Region (2021-2026)
6.2 APAC AI-Designed Small-Molecule Drugs Sales by Type (2021-2026)
6.3 APAC AI-Designed Small-Molecule Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe AI-Designed Small-Molecule Drugs by Country
7.1.1 Europe AI-Designed Small-Molecule Drugs Sales by Country (2021-2026)
7.1.2 Europe AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026)
7.2 Europe AI-Designed Small-Molecule Drugs Sales by Type (2021-2026)
7.3 Europe AI-Designed Small-Molecule Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI-Designed Small-Molecule Drugs by Country
8.1.1 Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of AI-Designed Small-Molecule Drugs
10.3 Manufacturing Process Analysis of AI-Designed Small-Molecule Drugs
10.4 Industry Chain Structure of AI-Designed Small-Molecule Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 AI-Designed Small-Molecule Drugs Distributors
11.3 AI-Designed Small-Molecule Drugs Customer
12 WORLD FORECAST REVIEW FOR AI-DESIGNED SMALL-MOLECULE DRUGS BY GEOGRAPHIC REGION
12.1 Global AI-Designed Small-Molecule Drugs Market Size Forecast by Region
12.1.1 Global AI-Designed Small-Molecule Drugs Forecast by Region (2027-2032)
12.1.2 Global AI-Designed Small-Molecule Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global AI-Designed Small-Molecule Drugs Forecast by Type (2027-2032)
12.7 Global AI-Designed Small-Molecule Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Recursion Pharmaceuticals
13.1.1 Recursion Pharmaceuticals Company Information
13.1.2 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.1.3 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Recursion Pharmaceuticals Main Business Overview
13.1.5 Recursion Pharmaceuticals Latest Developments
13.2 Insilico Medicine
13.2.1 Insilico Medicine Company Information
13.2.2 Insilico Medicine AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.2.3 Insilico Medicine AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Insilico Medicine Main Business Overview
13.2.5 Insilico Medicine Latest Developments
13.3 Schr?dinger
13.3.1 Schr?dinger Company Information
13.3.2 Schr?dinger AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.3.3 Schr?dinger AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Schr?dinger Main Business Overview
13.3.5 Schr?dinger Latest Developments
13.4 XtalPi
13.4.1 XtalPi Company Information
13.4.2 XtalPi AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.4.3 XtalPi AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 XtalPi Main Business Overview
13.4.5 XtalPi Latest Developments
13.5 Isomorphic Labs
13.5.1 Isomorphic Labs Company Information
13.5.2 Isomorphic Labs AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.5.3 Isomorphic Labs AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Isomorphic Labs Main Business Overview
13.5.5 Isomorphic Labs Latest Developments
13.6 Relay Therapeutics
13.6.1 Relay Therapeutics Company Information
13.6.2 Relay Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.6.3 Relay Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Relay Therapeutics Main Business Overview
13.6.5 Relay Therapeutics Latest Developments
13.7 Nimbus Therapeutics
13.7.1 Nimbus Therapeutics Company Information
13.7.2 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.7.3 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Nimbus Therapeutics Main Business Overview
13.7.5 Nimbus Therapeutics Latest Developments
13.8 Iambic Therapeutics
13.8.1 Iambic Therapeutics Company Information
13.8.2 Iambic Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.8.3 Iambic Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Iambic Therapeutics Main Business Overview
13.8.5 Iambic Therapeutics Latest Developments
13.9 BenevolentAI
13.9.1 BenevolentAI Company Information
13.9.2 BenevolentAI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.9.3 BenevolentAI AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BenevolentAI Main Business Overview
13.9.5 BenevolentAI Latest Developments
13.10 Accutar Biotechnology
13.10.1 Accutar Biotechnology Company Information
13.10.2 Accutar Biotechnology AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.10.3 Accutar Biotechnology AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Accutar Biotechnology Main Business Overview
13.10.5 Accutar Biotechnology Latest Developments
13.11 MindRank AI
13.11.1 MindRank AI Company Information
13.11.2 MindRank AI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.11.3 MindRank AI AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MindRank AI Main Business Overview
13.11.5 MindRank AI Latest Developments
13.12 Enveda Biosciences
13.12.1 Enveda Biosciences Company Information
13.12.2 Enveda Biosciences AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.12.3 Enveda Biosciences AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Enveda Biosciences Main Business Overview
13.12.5 Enveda Biosciences Latest Developments
13.13 Insitro
13.13.1 Insitro Company Information
13.13.2 Insitro AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.13.3 Insitro AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Insitro Main Business Overview
13.13.5 Insitro Latest Developments
13.14 Valo Health
13.14.1 Valo Health Company Information
13.14.2 Valo Health AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.14.3 Valo Health AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Valo Health Main Business Overview
13.14.5 Valo Health Latest Developments
13.15 Healx
13.15.1 Healx Company Information
13.15.2 Healx AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.15.3 Healx AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Healx Main Business Overview
13.15.5 Healx Latest Developments
13.16 Lantern Pharma
13.16.1 Lantern Pharma Company Information
13.16.2 Lantern Pharma AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.16.3 Lantern Pharma AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Lantern Pharma Main Business Overview
13.16.5 Lantern Pharma Latest Developments
13.17 Verge Labs
13.17.1 Verge Labs Company Information
13.17.2 Verge Labs AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.17.3 Verge Labs AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Verge Labs Main Business Overview
13.17.5 Verge Labs Latest Developments
13.18 DeepCure
13.18.1 DeepCure Company Information
13.18.2 DeepCure AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.18.3 DeepCure AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 DeepCure Main Business Overview
13.18.5 DeepCure Latest Developments
13.19 AQEMIA
13.19.1 AQEMIA Company Information
13.19.2 AQEMIA AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.19.3 AQEMIA AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 AQEMIA Main Business Overview
13.19.5 AQEMIA Latest Developments
13.20 Genesis Molecular AI
13.20.1 Genesis Molecular AI Company Information
13.20.2 Genesis Molecular AI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.20.3 Genesis Molecular AI AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Genesis Molecular AI Main Business Overview
13.20.5 Genesis Molecular AI Latest Developments
13.21 Terray Therapeutics
13.21.1 Terray Therapeutics Company Information
13.21.2 Terray Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.21.3 Terray Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Terray Therapeutics Main Business Overview
13.21.5 Terray Therapeutics Latest Developments
13.22 CHARM Therapeutics
13.22.1 CHARM Therapeutics Company Information
13.22.2 CHARM Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.22.3 CHARM Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 CHARM Therapeutics Main Business Overview
13.22.5 CHARM Therapeutics Latest Developments
13.23 Anagenex
13.23.1 Anagenex Company Information
13.23.2 Anagenex AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.23.3 Anagenex AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Anagenex Main Business Overview
13.23.5 Anagenex Latest Developments
13.24 StoneWise
13.24.1 StoneWise Company Information
13.24.2 StoneWise AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.24.3 StoneWise AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 StoneWise Main Business Overview
13.24.5 StoneWise Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI-Designed Small-Molecule Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for AI-Designed Small-Molecule Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for AI-Designed Small-Molecule Drugs by Country/Region, 2021, 2025 & 2032
2.2 AI-Designed Small-Molecule Drugs Segment by Type
2.2.1 Discovery-Stage Candidates
2.2.2 Preclinical Candidates
2.2.3 Clinical-Stage Candidates
2.2.4 Approved Drugs
2.2.5 AI-Designed Small-Molecule Drugs Sales by Type
2.2.5.1 Global AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global AI-Designed Small-Molecule Drugs Sale Price by Type (2021-2026)
2.3 AI-Designed Small-Molecule Drugs Segment by Mechanism of Action
2.3.1 Enzyme Inhibitors
2.3.2 Receptor Agonists
2.3.3 Receptor Antagonists
2.3.4 Targeted Protein Degraders
2.3.5 Molecular Glues
2.3.6 Other Small-Molecule Modulators
2.3.7 AI-Designed Small-Molecule Drugs Sales by Mechanism of Action
2.3.7.1 Global AI-Designed Small-Molecule Drugs Sales Market Share by Mechanism of Action (2021-2026)
2.3.7.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Mechanism of Action (2021-2026)
2.3.7.3 Global AI-Designed Small-Molecule Drugs Sale Price by Mechanism of Action (2021-2026)
2.4 AI-Designed Small-Molecule Drugs Segment by Route of Administration
2.4.1 Oral Drugs
2.4.2 Injectable Drugs
2.4.3 Inhaled Drugs
2.4.4 Topical Drugs
2.4.5 Other Administration Routes
2.4.6 AI-Designed Small-Molecule Drugs Sales by Route of Administration
2.4.6.1 Global AI-Designed Small-Molecule Drugs Sales Market Share by Route of Administration (2021-2026)
2.4.6.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Route of Administration (2021-2026)
2.4.6.3 Global AI-Designed Small-Molecule Drugs Sale Price by Route of Administration (2021-2026)
2.5 AI-Designed Small-Molecule Drugs Segment by Target Class
2.5.1 Kinases
2.5.2 Other Enzymes
2.5.3 G Protein-Coupled Receptors
2.5.4 Nuclear Receptors
2.5.5 Protein–Protein Interaction Targets
2.5.6 Nucleic Acid Targets
2.5.7 Other Target Classes
2.5.8 AI-Designed Small-Molecule Drugs Sales by Target Class
2.5.8.1 Global AI-Designed Small-Molecule Drugs Sales Market Share by Target Class (2021-2026)
2.5.8.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Target Class (2021-2026)
2.5.8.3 Global AI-Designed Small-Molecule Drugs Sale Price by Target Class (2021-2026)
2.6 AI-Designed Small-Molecule Drugs Segment by Application
2.6.1 Oncology
2.6.2 Immunology and Inflammation
2.6.3 Neurology and Psychiatry
2.6.4 Metabolic and Cardiovascular Diseases
2.6.5 Infectious Diseases
2.6.6 Other Therapeutic Areas
2.6.7 AI-Designed Small-Molecule Drugs Sales by Application
2.6.7.1 Global AI-Designed Small-Molecule Drugs Sale Market Share by Application (2021-2026)
2.6.7.2 Global AI-Designed Small-Molecule Drugs Revenue and Market Share by Application (2021-2026)
2.6.7.3 Global AI-Designed Small-Molecule Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global AI-Designed Small-Molecule Drugs Breakdown Data by Company
3.1.1 Global AI-Designed Small-Molecule Drugs Annual Sales by Company (2021-2026)
3.1.2 Global AI-Designed Small-Molecule Drugs Sales Market Share by Company (2021-2026)
3.2 Global AI-Designed Small-Molecule Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global AI-Designed Small-Molecule Drugs Revenue by Company (2021-2026)
3.2.2 Global AI-Designed Small-Molecule Drugs Revenue Market Share by Company (2021-2026)
3.3 Global AI-Designed Small-Molecule Drugs Sale Price by Company
3.4 Key Manufacturers AI-Designed Small-Molecule Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers AI-Designed Small-Molecule Drugs Product Location Distribution
3.4.2 Players AI-Designed Small-Molecule Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AI-DESIGNED SMALL-MOLECULE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic AI-Designed Small-Molecule Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global AI-Designed Small-Molecule Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global AI-Designed Small-Molecule Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic AI-Designed Small-Molecule Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global AI-Designed Small-Molecule Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global AI-Designed Small-Molecule Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI-Designed Small-Molecule Drugs Sales Growth
4.4 APAC AI-Designed Small-Molecule Drugs Sales Growth
4.5 Europe AI-Designed Small-Molecule Drugs Sales Growth
4.6 Middle East & Africa AI-Designed Small-Molecule Drugs Sales Growth
5 AMERICAS
5.1 Americas AI-Designed Small-Molecule Drugs Sales by Country
5.1.1 Americas AI-Designed Small-Molecule Drugs Sales by Country (2021-2026)
5.1.2 Americas AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026)
5.2 Americas AI-Designed Small-Molecule Drugs Sales by Type (2021-2026)
5.3 Americas AI-Designed Small-Molecule Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-Designed Small-Molecule Drugs Sales by Region
6.1.1 APAC AI-Designed Small-Molecule Drugs Sales by Region (2021-2026)
6.1.2 APAC AI-Designed Small-Molecule Drugs Revenue by Region (2021-2026)
6.2 APAC AI-Designed Small-Molecule Drugs Sales by Type (2021-2026)
6.3 APAC AI-Designed Small-Molecule Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe AI-Designed Small-Molecule Drugs by Country
7.1.1 Europe AI-Designed Small-Molecule Drugs Sales by Country (2021-2026)
7.1.2 Europe AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026)
7.2 Europe AI-Designed Small-Molecule Drugs Sales by Type (2021-2026)
7.3 Europe AI-Designed Small-Molecule Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI-Designed Small-Molecule Drugs by Country
8.1.1 Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of AI-Designed Small-Molecule Drugs
10.3 Manufacturing Process Analysis of AI-Designed Small-Molecule Drugs
10.4 Industry Chain Structure of AI-Designed Small-Molecule Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 AI-Designed Small-Molecule Drugs Distributors
11.3 AI-Designed Small-Molecule Drugs Customer
12 WORLD FORECAST REVIEW FOR AI-DESIGNED SMALL-MOLECULE DRUGS BY GEOGRAPHIC REGION
12.1 Global AI-Designed Small-Molecule Drugs Market Size Forecast by Region
12.1.1 Global AI-Designed Small-Molecule Drugs Forecast by Region (2027-2032)
12.1.2 Global AI-Designed Small-Molecule Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global AI-Designed Small-Molecule Drugs Forecast by Type (2027-2032)
12.7 Global AI-Designed Small-Molecule Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Recursion Pharmaceuticals
13.1.1 Recursion Pharmaceuticals Company Information
13.1.2 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.1.3 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Recursion Pharmaceuticals Main Business Overview
13.1.5 Recursion Pharmaceuticals Latest Developments
13.2 Insilico Medicine
13.2.1 Insilico Medicine Company Information
13.2.2 Insilico Medicine AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.2.3 Insilico Medicine AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Insilico Medicine Main Business Overview
13.2.5 Insilico Medicine Latest Developments
13.3 Schr?dinger
13.3.1 Schr?dinger Company Information
13.3.2 Schr?dinger AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.3.3 Schr?dinger AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Schr?dinger Main Business Overview
13.3.5 Schr?dinger Latest Developments
13.4 XtalPi
13.4.1 XtalPi Company Information
13.4.2 XtalPi AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.4.3 XtalPi AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 XtalPi Main Business Overview
13.4.5 XtalPi Latest Developments
13.5 Isomorphic Labs
13.5.1 Isomorphic Labs Company Information
13.5.2 Isomorphic Labs AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.5.3 Isomorphic Labs AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Isomorphic Labs Main Business Overview
13.5.5 Isomorphic Labs Latest Developments
13.6 Relay Therapeutics
13.6.1 Relay Therapeutics Company Information
13.6.2 Relay Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.6.3 Relay Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Relay Therapeutics Main Business Overview
13.6.5 Relay Therapeutics Latest Developments
13.7 Nimbus Therapeutics
13.7.1 Nimbus Therapeutics Company Information
13.7.2 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.7.3 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Nimbus Therapeutics Main Business Overview
13.7.5 Nimbus Therapeutics Latest Developments
13.8 Iambic Therapeutics
13.8.1 Iambic Therapeutics Company Information
13.8.2 Iambic Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.8.3 Iambic Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Iambic Therapeutics Main Business Overview
13.8.5 Iambic Therapeutics Latest Developments
13.9 BenevolentAI
13.9.1 BenevolentAI Company Information
13.9.2 BenevolentAI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.9.3 BenevolentAI AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BenevolentAI Main Business Overview
13.9.5 BenevolentAI Latest Developments
13.10 Accutar Biotechnology
13.10.1 Accutar Biotechnology Company Information
13.10.2 Accutar Biotechnology AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.10.3 Accutar Biotechnology AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Accutar Biotechnology Main Business Overview
13.10.5 Accutar Biotechnology Latest Developments
13.11 MindRank AI
13.11.1 MindRank AI Company Information
13.11.2 MindRank AI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.11.3 MindRank AI AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MindRank AI Main Business Overview
13.11.5 MindRank AI Latest Developments
13.12 Enveda Biosciences
13.12.1 Enveda Biosciences Company Information
13.12.2 Enveda Biosciences AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.12.3 Enveda Biosciences AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Enveda Biosciences Main Business Overview
13.12.5 Enveda Biosciences Latest Developments
13.13 Insitro
13.13.1 Insitro Company Information
13.13.2 Insitro AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.13.3 Insitro AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Insitro Main Business Overview
13.13.5 Insitro Latest Developments
13.14 Valo Health
13.14.1 Valo Health Company Information
13.14.2 Valo Health AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.14.3 Valo Health AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Valo Health Main Business Overview
13.14.5 Valo Health Latest Developments
13.15 Healx
13.15.1 Healx Company Information
13.15.2 Healx AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.15.3 Healx AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Healx Main Business Overview
13.15.5 Healx Latest Developments
13.16 Lantern Pharma
13.16.1 Lantern Pharma Company Information
13.16.2 Lantern Pharma AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.16.3 Lantern Pharma AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Lantern Pharma Main Business Overview
13.16.5 Lantern Pharma Latest Developments
13.17 Verge Labs
13.17.1 Verge Labs Company Information
13.17.2 Verge Labs AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.17.3 Verge Labs AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Verge Labs Main Business Overview
13.17.5 Verge Labs Latest Developments
13.18 DeepCure
13.18.1 DeepCure Company Information
13.18.2 DeepCure AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.18.3 DeepCure AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 DeepCure Main Business Overview
13.18.5 DeepCure Latest Developments
13.19 AQEMIA
13.19.1 AQEMIA Company Information
13.19.2 AQEMIA AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.19.3 AQEMIA AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 AQEMIA Main Business Overview
13.19.5 AQEMIA Latest Developments
13.20 Genesis Molecular AI
13.20.1 Genesis Molecular AI Company Information
13.20.2 Genesis Molecular AI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.20.3 Genesis Molecular AI AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Genesis Molecular AI Main Business Overview
13.20.5 Genesis Molecular AI Latest Developments
13.21 Terray Therapeutics
13.21.1 Terray Therapeutics Company Information
13.21.2 Terray Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.21.3 Terray Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Terray Therapeutics Main Business Overview
13.21.5 Terray Therapeutics Latest Developments
13.22 CHARM Therapeutics
13.22.1 CHARM Therapeutics Company Information
13.22.2 CHARM Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.22.3 CHARM Therapeutics AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 CHARM Therapeutics Main Business Overview
13.22.5 CHARM Therapeutics Latest Developments
13.23 Anagenex
13.23.1 Anagenex Company Information
13.23.2 Anagenex AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.23.3 Anagenex AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Anagenex Main Business Overview
13.23.5 Anagenex Latest Developments
13.24 StoneWise
13.24.1 StoneWise Company Information
13.24.2 StoneWise AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
13.24.3 StoneWise AI-Designed Small-Molecule Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 StoneWise Main Business Overview
13.24.5 StoneWise Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AI-Designed Small-Molecule Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. AI-Designed Small-Molecule Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Discovery-Stage Candidates
Table 4. Major Players of Preclinical Candidates
Table 5. Major Players of Clinical-Stage Candidates
Table 6. Major Players of Approved Drugs
Table 7. Global AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 8. Global AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Table 9. Global AI-Designed Small-Molecule Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global AI-Designed Small-Molecule Drugs Sale Price by Type (2021-2026) & (US$/Dose)
Table 12. Major Players of Enzyme Inhibitors
Table 13. Major Players of Receptor Agonists
Table 14. Major Players of Receptor Antagonists
Table 15. Major Players of Targeted Protein Degraders
Table 16. Major Players of Molecular Glues
Table 17. Major Players of Other Small-Molecule Modulators
Table 18. Global AI-Designed Small-Molecule Drugs Sales by Mechanism of Action (2021-2026) & (K Dose)
Table 19. Global AI-Designed Small-Molecule Drugs Sales Market Share by Mechanism of Action (2021-2026)
Table 20. Global AI-Designed Small-Molecule Drugs Revenue by Mechanism of Action (2021-2026) & ($ million)
Table 21. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Mechanism of Action (2021-2026)
Table 22. Global AI-Designed Small-Molecule Drugs Sale Price by Mechanism of Action (2021-2026) & (US$/Dose)
Table 23. Major Players of Oral Drugs
Table 24. Major Players of Injectable Drugs
Table 25. Major Players of Inhaled Drugs
Table 26. Major Players of Topical Drugs
Table 27. Major Players of Other Administration Routes
Table 28. Global AI-Designed Small-Molecule Drugs Sales by Route of Administration (2021-2026) & (K Dose)
Table 29. Global AI-Designed Small-Molecule Drugs Sales Market Share by Route of Administration (2021-2026)
Table 30. Global AI-Designed Small-Molecule Drugs Revenue by Route of Administration (2021-2026) & ($ million)
Table 31. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Route of Administration (2021-2026)
Table 32. Global AI-Designed Small-Molecule Drugs Sale Price by Route of Administration (2021-2026) & (US$/Dose)
Table 33. Major Players of Kinases
Table 34. Major Players of Other Enzymes
Table 35. Major Players of G Protein-Coupled Receptors
Table 36. Major Players of Nuclear Receptors
Table 37. Major Players of Protein–Protein Interaction Targets
Table 38. Major Players of Nucleic Acid Targets
Table 39. Major Players of Other Target Classes
Table 40. Global AI-Designed Small-Molecule Drugs Sales by Target Class (2021-2026) & (K Dose)
Table 41. Global AI-Designed Small-Molecule Drugs Sales Market Share by Target Class (2021-2026)
Table 42. Global AI-Designed Small-Molecule Drugs Revenue by Target Class (2021-2026) & ($ million)
Table 43. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Target Class (2021-2026)
Table 44. Global AI-Designed Small-Molecule Drugs Sale Price by Target Class (2021-2026) & (US$/Dose)
Table 45. Global AI-Designed Small-Molecule Drugs Sale by Application (2021-2026) & (K Dose)
Table 46. Global AI-Designed Small-Molecule Drugs Sale Market Share by Application (2021-2026)
Table 47. Global AI-Designed Small-Molecule Drugs Revenue by Application (2021-2026) & ($ million)
Table 48. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Application (2021-2026)
Table 49. Global AI-Designed Small-Molecule Drugs Sale Price by Application (2021-2026) & (US$/Dose)
Table 50. Global AI-Designed Small-Molecule Drugs Sales by Company (2021-2026) & (K Dose)
Table 51. Global AI-Designed Small-Molecule Drugs Sales Market Share by Company (2021-2026)
Table 52. Global AI-Designed Small-Molecule Drugs Revenue by Company (2021-2026) & ($ millions)
Table 53. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Company (2021-2026)
Table 54. Global AI-Designed Small-Molecule Drugs Sale Price by Company (2021-2026) & (US$/Dose)
Table 55. Key Manufacturers AI-Designed Small-Molecule Drugs Producing Area Distribution and Sales Area
Table 56. Players AI-Designed Small-Molecule Drugs Products Offered
Table 57. AI-Designed Small-Molecule Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 58. New Products and Potential Entrants
Table 59. Market M&A Activity & Strategy
Table 60. Global AI-Designed Small-Molecule Drugs Sales by Geographic Region (2021-2026) & (K Dose)
Table 61. Global AI-Designed Small-Molecule Drugs Sales Market Share Geographic Region (2021-2026)
Table 62. Global AI-Designed Small-Molecule Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 63. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 64. Global AI-Designed Small-Molecule Drugs Sales by Country/Region (2021-2026) & (K Dose)
Table 65. Global AI-Designed Small-Molecule Drugs Sales Market Share by Country/Region (2021-2026)
Table 66. Global AI-Designed Small-Molecule Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 67. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Country/Region (2021-2026)
Table 68. Americas AI-Designed Small-Molecule Drugs Sales by Country (2021-2026) & (K Dose)
Table 69. Americas AI-Designed Small-Molecule Drugs Sales Market Share by Country (2021-2026)
Table 70. Americas AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026) & ($ millions)
Table 71. Americas AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 72. Americas AI-Designed Small-Molecule Drugs Sales by Application (2021-2026) & (K Dose)
Table 73. APAC AI-Designed Small-Molecule Drugs Sales by Region (2021-2026) & (K Dose)
Table 74. APAC AI-Designed Small-Molecule Drugs Sales Market Share by Region (2021-2026)
Table 75. APAC AI-Designed Small-Molecule Drugs Revenue by Region (2021-2026) & ($ millions)
Table 76. APAC AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 77. APAC AI-Designed Small-Molecule Drugs Sales by Application (2021-2026) & (K Dose)
Table 78. Europe AI-Designed Small-Molecule Drugs Sales by Country (2021-2026) & (K Dose)
Table 79. Europe AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026) & ($ millions)
Table 80. Europe AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 81. Europe AI-Designed Small-Molecule Drugs Sales by Application (2021-2026) & (K Dose)
Table 82. Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Country (2021-2026) & (K Dose)
Table 83. Middle East & Africa AI-Designed Small-Molecule Drugs Revenue Market Share by Country (2021-2026)
Table 84. Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 85. Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Application (2021-2026) & (K Dose)
Table 86. Key Market Drivers & Growth Opportunities of AI-Designed Small-Molecule Drugs
Table 87. Key Market Challenges & Risks of AI-Designed Small-Molecule Drugs
Table 88. Key Industry Trends of AI-Designed Small-Molecule Drugs
Table 89. AI-Designed Small-Molecule Drugs Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. AI-Designed Small-Molecule Drugs Distributors List
Table 92. AI-Designed Small-Molecule Drugs Customer List
Table 93. Global AI-Designed Small-Molecule Drugs Sales Forecast by Region (2027-2032) & (K Dose)
Table 94. Global AI-Designed Small-Molecule Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 95. Americas AI-Designed Small-Molecule Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 96. Americas AI-Designed Small-Molecule Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 97. APAC AI-Designed Small-Molecule Drugs Sales Forecast by Region (2027-2032) & (K Dose)
Table 98. APAC AI-Designed Small-Molecule Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 99. Europe AI-Designed Small-Molecule Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 100. Europe AI-Designed Small-Molecule Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 101. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 102. Middle East & Africa AI-Designed Small-Molecule Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 103. Global AI-Designed Small-Molecule Drugs Sales Forecast by Type (2027-2032) & (K Dose)
Table 104. Global AI-Designed Small-Molecule Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 105. Global AI-Designed Small-Molecule Drugs Sales Forecast by Application (2027-2032) & (K Dose)
Table 106. Global AI-Designed Small-Molecule Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 107. Recursion Pharmaceuticals Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 109. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Recursion Pharmaceuticals Main Business
Table 111. Recursion Pharmaceuticals Latest Developments
Table 112. Insilico Medicine Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Insilico Medicine AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 114. Insilico Medicine AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Insilico Medicine Main Business
Table 116. Insilico Medicine Latest Developments
Table 117. Schr?dinger Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Schr?dinger AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 119. Schr?dinger AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. Schr?dinger Main Business
Table 121. Schr?dinger Latest Developments
Table 122. XtalPi Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. XtalPi AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 124. XtalPi AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. XtalPi Main Business
Table 126. XtalPi Latest Developments
Table 127. Isomorphic Labs Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Isomorphic Labs AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 129. Isomorphic Labs AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 130. Isomorphic Labs Main Business
Table 131. Isomorphic Labs Latest Developments
Table 132. Relay Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Relay Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 134. Relay Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 135. Relay Therapeutics Main Business
Table 136. Relay Therapeutics Latest Developments
Table 137. Nimbus Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 139. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 140. Nimbus Therapeutics Main Business
Table 141. Nimbus Therapeutics Latest Developments
Table 142. Iambic Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Iambic Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 144. Iambic Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 145. Iambic Therapeutics Main Business
Table 146. Iambic Therapeutics Latest Developments
Table 147. BenevolentAI Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. BenevolentAI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 149. BenevolentAI AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 150. BenevolentAI Main Business
Table 151. BenevolentAI Latest Developments
Table 152. Accutar Biotechnology Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Accutar Biotechnology AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 154. Accutar Biotechnology AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 155. Accutar Biotechnology Main Business
Table 156. Accutar Biotechnology Latest Developments
Table 157. MindRank AI Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. MindRank AI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 159. MindRank AI AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 160. MindRank AI Main Business
Table 161. MindRank AI Latest Developments
Table 162. Enveda Biosciences Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Enveda Biosciences AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 164. Enveda Biosciences AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 165. Enveda Biosciences Main Business
Table 166. Enveda Biosciences Latest Developments
Table 167. Insitro Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Insitro AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 169. Insitro AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 170. Insitro Main Business
Table 171. Insitro Latest Developments
Table 172. Valo Health Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 173. Valo Health AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 174. Valo Health AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 175. Valo Health Main Business
Table 176. Valo Health Latest Developments
Table 177. Healx Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 178. Healx AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 179. Healx AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 180. Healx Main Business
Table 181. Healx Latest Developments
Table 182. Lantern Pharma Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 183. Lantern Pharma AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 184. Lantern Pharma AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 185. Lantern Pharma Main Business
Table 186. Lantern Pharma Latest Developments
Table 187. Verge Labs Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 188. Verge Labs AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 189. Verge Labs AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 190. Verge Labs Main Business
Table 191. Verge Labs Latest Developments
Table 192. DeepCure Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 193. DeepCure AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 194. DeepCure AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 195. DeepCure Main Business
Table 196. DeepCure Latest Developments
Table 197. AQEMIA Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 198. AQEMIA AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 199. AQEMIA AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 200. AQEMIA Main Business
Table 201. AQEMIA Latest Developments
Table 202. Genesis Molecular AI Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 203. Genesis Molecular AI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 204. Genesis Molecular AI AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 205. Genesis Molecular AI Main Business
Table 206. Genesis Molecular AI Latest Developments
Table 207. Terray Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 208. Terray Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 209. Terray Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 210. Terray Therapeutics Main Business
Table 211. Terray Therapeutics Latest Developments
Table 212. CHARM Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 213. CHARM Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 214. CHARM Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 215. CHARM Therapeutics Main Business
Table 216. CHARM Therapeutics Latest Developments
Table 217. Anagenex Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 218. Anagenex AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 219. Anagenex AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 220. Anagenex Main Business
Table 221. Anagenex Latest Developments
Table 222. StoneWise Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 223. StoneWise AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 224. StoneWise AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 225. StoneWise Main Business
Table 226. StoneWise Latest Developments
Table 1. AI-Designed Small-Molecule Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. AI-Designed Small-Molecule Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Discovery-Stage Candidates
Table 4. Major Players of Preclinical Candidates
Table 5. Major Players of Clinical-Stage Candidates
Table 6. Major Players of Approved Drugs
Table 7. Global AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 8. Global AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Table 9. Global AI-Designed Small-Molecule Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global AI-Designed Small-Molecule Drugs Sale Price by Type (2021-2026) & (US$/Dose)
Table 12. Major Players of Enzyme Inhibitors
Table 13. Major Players of Receptor Agonists
Table 14. Major Players of Receptor Antagonists
Table 15. Major Players of Targeted Protein Degraders
Table 16. Major Players of Molecular Glues
Table 17. Major Players of Other Small-Molecule Modulators
Table 18. Global AI-Designed Small-Molecule Drugs Sales by Mechanism of Action (2021-2026) & (K Dose)
Table 19. Global AI-Designed Small-Molecule Drugs Sales Market Share by Mechanism of Action (2021-2026)
Table 20. Global AI-Designed Small-Molecule Drugs Revenue by Mechanism of Action (2021-2026) & ($ million)
Table 21. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Mechanism of Action (2021-2026)
Table 22. Global AI-Designed Small-Molecule Drugs Sale Price by Mechanism of Action (2021-2026) & (US$/Dose)
Table 23. Major Players of Oral Drugs
Table 24. Major Players of Injectable Drugs
Table 25. Major Players of Inhaled Drugs
Table 26. Major Players of Topical Drugs
Table 27. Major Players of Other Administration Routes
Table 28. Global AI-Designed Small-Molecule Drugs Sales by Route of Administration (2021-2026) & (K Dose)
Table 29. Global AI-Designed Small-Molecule Drugs Sales Market Share by Route of Administration (2021-2026)
Table 30. Global AI-Designed Small-Molecule Drugs Revenue by Route of Administration (2021-2026) & ($ million)
Table 31. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Route of Administration (2021-2026)
Table 32. Global AI-Designed Small-Molecule Drugs Sale Price by Route of Administration (2021-2026) & (US$/Dose)
Table 33. Major Players of Kinases
Table 34. Major Players of Other Enzymes
Table 35. Major Players of G Protein-Coupled Receptors
Table 36. Major Players of Nuclear Receptors
Table 37. Major Players of Protein–Protein Interaction Targets
Table 38. Major Players of Nucleic Acid Targets
Table 39. Major Players of Other Target Classes
Table 40. Global AI-Designed Small-Molecule Drugs Sales by Target Class (2021-2026) & (K Dose)
Table 41. Global AI-Designed Small-Molecule Drugs Sales Market Share by Target Class (2021-2026)
Table 42. Global AI-Designed Small-Molecule Drugs Revenue by Target Class (2021-2026) & ($ million)
Table 43. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Target Class (2021-2026)
Table 44. Global AI-Designed Small-Molecule Drugs Sale Price by Target Class (2021-2026) & (US$/Dose)
Table 45. Global AI-Designed Small-Molecule Drugs Sale by Application (2021-2026) & (K Dose)
Table 46. Global AI-Designed Small-Molecule Drugs Sale Market Share by Application (2021-2026)
Table 47. Global AI-Designed Small-Molecule Drugs Revenue by Application (2021-2026) & ($ million)
Table 48. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Application (2021-2026)
Table 49. Global AI-Designed Small-Molecule Drugs Sale Price by Application (2021-2026) & (US$/Dose)
Table 50. Global AI-Designed Small-Molecule Drugs Sales by Company (2021-2026) & (K Dose)
Table 51. Global AI-Designed Small-Molecule Drugs Sales Market Share by Company (2021-2026)
Table 52. Global AI-Designed Small-Molecule Drugs Revenue by Company (2021-2026) & ($ millions)
Table 53. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Company (2021-2026)
Table 54. Global AI-Designed Small-Molecule Drugs Sale Price by Company (2021-2026) & (US$/Dose)
Table 55. Key Manufacturers AI-Designed Small-Molecule Drugs Producing Area Distribution and Sales Area
Table 56. Players AI-Designed Small-Molecule Drugs Products Offered
Table 57. AI-Designed Small-Molecule Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 58. New Products and Potential Entrants
Table 59. Market M&A Activity & Strategy
Table 60. Global AI-Designed Small-Molecule Drugs Sales by Geographic Region (2021-2026) & (K Dose)
Table 61. Global AI-Designed Small-Molecule Drugs Sales Market Share Geographic Region (2021-2026)
Table 62. Global AI-Designed Small-Molecule Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 63. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 64. Global AI-Designed Small-Molecule Drugs Sales by Country/Region (2021-2026) & (K Dose)
Table 65. Global AI-Designed Small-Molecule Drugs Sales Market Share by Country/Region (2021-2026)
Table 66. Global AI-Designed Small-Molecule Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 67. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Country/Region (2021-2026)
Table 68. Americas AI-Designed Small-Molecule Drugs Sales by Country (2021-2026) & (K Dose)
Table 69. Americas AI-Designed Small-Molecule Drugs Sales Market Share by Country (2021-2026)
Table 70. Americas AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026) & ($ millions)
Table 71. Americas AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 72. Americas AI-Designed Small-Molecule Drugs Sales by Application (2021-2026) & (K Dose)
Table 73. APAC AI-Designed Small-Molecule Drugs Sales by Region (2021-2026) & (K Dose)
Table 74. APAC AI-Designed Small-Molecule Drugs Sales Market Share by Region (2021-2026)
Table 75. APAC AI-Designed Small-Molecule Drugs Revenue by Region (2021-2026) & ($ millions)
Table 76. APAC AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 77. APAC AI-Designed Small-Molecule Drugs Sales by Application (2021-2026) & (K Dose)
Table 78. Europe AI-Designed Small-Molecule Drugs Sales by Country (2021-2026) & (K Dose)
Table 79. Europe AI-Designed Small-Molecule Drugs Revenue by Country (2021-2026) & ($ millions)
Table 80. Europe AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 81. Europe AI-Designed Small-Molecule Drugs Sales by Application (2021-2026) & (K Dose)
Table 82. Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Country (2021-2026) & (K Dose)
Table 83. Middle East & Africa AI-Designed Small-Molecule Drugs Revenue Market Share by Country (2021-2026)
Table 84. Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Type (2021-2026) & (K Dose)
Table 85. Middle East & Africa AI-Designed Small-Molecule Drugs Sales by Application (2021-2026) & (K Dose)
Table 86. Key Market Drivers & Growth Opportunities of AI-Designed Small-Molecule Drugs
Table 87. Key Market Challenges & Risks of AI-Designed Small-Molecule Drugs
Table 88. Key Industry Trends of AI-Designed Small-Molecule Drugs
Table 89. AI-Designed Small-Molecule Drugs Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. AI-Designed Small-Molecule Drugs Distributors List
Table 92. AI-Designed Small-Molecule Drugs Customer List
Table 93. Global AI-Designed Small-Molecule Drugs Sales Forecast by Region (2027-2032) & (K Dose)
Table 94. Global AI-Designed Small-Molecule Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 95. Americas AI-Designed Small-Molecule Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 96. Americas AI-Designed Small-Molecule Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 97. APAC AI-Designed Small-Molecule Drugs Sales Forecast by Region (2027-2032) & (K Dose)
Table 98. APAC AI-Designed Small-Molecule Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 99. Europe AI-Designed Small-Molecule Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 100. Europe AI-Designed Small-Molecule Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 101. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 102. Middle East & Africa AI-Designed Small-Molecule Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 103. Global AI-Designed Small-Molecule Drugs Sales Forecast by Type (2027-2032) & (K Dose)
Table 104. Global AI-Designed Small-Molecule Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 105. Global AI-Designed Small-Molecule Drugs Sales Forecast by Application (2027-2032) & (K Dose)
Table 106. Global AI-Designed Small-Molecule Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 107. Recursion Pharmaceuticals Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 109. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Recursion Pharmaceuticals Main Business
Table 111. Recursion Pharmaceuticals Latest Developments
Table 112. Insilico Medicine Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Insilico Medicine AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 114. Insilico Medicine AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Insilico Medicine Main Business
Table 116. Insilico Medicine Latest Developments
Table 117. Schr?dinger Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Schr?dinger AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 119. Schr?dinger AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. Schr?dinger Main Business
Table 121. Schr?dinger Latest Developments
Table 122. XtalPi Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. XtalPi AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 124. XtalPi AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. XtalPi Main Business
Table 126. XtalPi Latest Developments
Table 127. Isomorphic Labs Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Isomorphic Labs AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 129. Isomorphic Labs AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 130. Isomorphic Labs Main Business
Table 131. Isomorphic Labs Latest Developments
Table 132. Relay Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Relay Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 134. Relay Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 135. Relay Therapeutics Main Business
Table 136. Relay Therapeutics Latest Developments
Table 137. Nimbus Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 139. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 140. Nimbus Therapeutics Main Business
Table 141. Nimbus Therapeutics Latest Developments
Table 142. Iambic Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Iambic Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 144. Iambic Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 145. Iambic Therapeutics Main Business
Table 146. Iambic Therapeutics Latest Developments
Table 147. BenevolentAI Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. BenevolentAI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 149. BenevolentAI AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 150. BenevolentAI Main Business
Table 151. BenevolentAI Latest Developments
Table 152. Accutar Biotechnology Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Accutar Biotechnology AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 154. Accutar Biotechnology AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 155. Accutar Biotechnology Main Business
Table 156. Accutar Biotechnology Latest Developments
Table 157. MindRank AI Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. MindRank AI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 159. MindRank AI AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 160. MindRank AI Main Business
Table 161. MindRank AI Latest Developments
Table 162. Enveda Biosciences Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Enveda Biosciences AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 164. Enveda Biosciences AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 165. Enveda Biosciences Main Business
Table 166. Enveda Biosciences Latest Developments
Table 167. Insitro Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Insitro AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 169. Insitro AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 170. Insitro Main Business
Table 171. Insitro Latest Developments
Table 172. Valo Health Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 173. Valo Health AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 174. Valo Health AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 175. Valo Health Main Business
Table 176. Valo Health Latest Developments
Table 177. Healx Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 178. Healx AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 179. Healx AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 180. Healx Main Business
Table 181. Healx Latest Developments
Table 182. Lantern Pharma Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 183. Lantern Pharma AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 184. Lantern Pharma AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 185. Lantern Pharma Main Business
Table 186. Lantern Pharma Latest Developments
Table 187. Verge Labs Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 188. Verge Labs AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 189. Verge Labs AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 190. Verge Labs Main Business
Table 191. Verge Labs Latest Developments
Table 192. DeepCure Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 193. DeepCure AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 194. DeepCure AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 195. DeepCure Main Business
Table 196. DeepCure Latest Developments
Table 197. AQEMIA Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 198. AQEMIA AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 199. AQEMIA AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 200. AQEMIA Main Business
Table 201. AQEMIA Latest Developments
Table 202. Genesis Molecular AI Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 203. Genesis Molecular AI AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 204. Genesis Molecular AI AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 205. Genesis Molecular AI Main Business
Table 206. Genesis Molecular AI Latest Developments
Table 207. Terray Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 208. Terray Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 209. Terray Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 210. Terray Therapeutics Main Business
Table 211. Terray Therapeutics Latest Developments
Table 212. CHARM Therapeutics Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 213. CHARM Therapeutics AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 214. CHARM Therapeutics AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 215. CHARM Therapeutics Main Business
Table 216. CHARM Therapeutics Latest Developments
Table 217. Anagenex Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 218. Anagenex AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 219. Anagenex AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 220. Anagenex Main Business
Table 221. Anagenex Latest Developments
Table 222. StoneWise Basic Information, AI-Designed Small-Molecule Drugs Manufacturing Base, Sales Area and Its Competitors
Table 223. StoneWise AI-Designed Small-Molecule Drugs Product Portfolios and Specifications
Table 224. StoneWise AI-Designed Small-Molecule Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 225. StoneWise Main Business
Table 226. StoneWise Latest Developments
LIST OF FIGURES
Figure 1. Picture of AI-Designed Small-Molecule Drugs
Figure 2. AI-Designed Small-Molecule Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AI-Designed Small-Molecule Drugs Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global AI-Designed Small-Molecule Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. AI-Designed Small-Molecule Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. AI-Designed Small-Molecule Drugs Sales Market Share by Country/Region (2025)
Figure 10. AI-Designed Small-Molecule Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Discovery-Stage Candidates
Figure 12. Product Picture of Preclinical Candidates
Figure 13. Product Picture of Clinical-Stage Candidates
Figure 14. Product Picture of Approved Drugs
Figure 15. Global AI-Designed Small-Molecule Drugs Sales Market Share by Type in 2026
Figure 16. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Enzyme Inhibitors
Figure 18. Product Picture of Receptor Agonists
Figure 19. Product Picture of Receptor Antagonists
Figure 20. Product Picture of Targeted Protein Degraders
Figure 21. Product Picture of Molecular Glues
Figure 22. Product Picture of Other Small-Molecule Modulators
Figure 23. Global AI-Designed Small-Molecule Drugs Sales Market Share by Mechanism of Action in 2026
Figure 24. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Mechanism of Action (2021-2026)
Figure 25. Product Picture of Oral Drugs
Figure 26. Product Picture of Injectable Drugs
Figure 27. Product Picture of Inhaled Drugs
Figure 28. Product Picture of Topical Drugs
Figure 29. Product Picture of Other Administration Routes
Figure 30. Global AI-Designed Small-Molecule Drugs Sales Market Share by Route of Administration in 2026
Figure 31. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Route of Administration (2021-2026)
Figure 32. Product Picture of Kinases
Figure 33. Product Picture of Other Enzymes
Figure 34. Product Picture of G Protein-Coupled Receptors
Figure 35. Product Picture of Nuclear Receptors
Figure 36. Product Picture of Protein–Protein Interaction Targets
Figure 37. Product Picture of Nucleic Acid Targets
Figure 38. Product Picture of Other Target Classes
Figure 39. Global AI-Designed Small-Molecule Drugs Sales Market Share by Target Class in 2026
Figure 40. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Target Class (2021-2026)
Figure 41. AI-Designed Small-Molecule Drugs Consumed in Oncology
Figure 42. Global AI-Designed Small-Molecule Drugs Market: Oncology (2021-2026) & (K Dose)
Figure 43. AI-Designed Small-Molecule Drugs Consumed in Immunology and Inflammation
Figure 44. Global AI-Designed Small-Molecule Drugs Market: Immunology and Inflammation (2021-2026) & (K Dose)
Figure 45. AI-Designed Small-Molecule Drugs Consumed in Neurology and Psychiatry
Figure 46. Global AI-Designed Small-Molecule Drugs Market: Neurology and Psychiatry (2021-2026) & (K Dose)
Figure 47. AI-Designed Small-Molecule Drugs Consumed in Metabolic and Cardiovascular Diseases
Figure 48. Global AI-Designed Small-Molecule Drugs Market: Metabolic and Cardiovascular Diseases (2021-2026) & (K Dose)
Figure 49. AI-Designed Small-Molecule Drugs Consumed in Infectious Diseases
Figure 50. Global AI-Designed Small-Molecule Drugs Market: Infectious Diseases (2021-2026) & (K Dose)
Figure 51. AI-Designed Small-Molecule Drugs Consumed in Other Therapeutic Areas
Figure 52. Global AI-Designed Small-Molecule Drugs Market: Other Therapeutic Areas (2021-2026) & (K Dose)
Figure 53. Global AI-Designed Small-Molecule Drugs Sale Market Share by Application (2025)
Figure 54. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Application in 2025
Figure 55. AI-Designed Small-Molecule Drugs Sales by Company in 2025 (K Dose)
Figure 56. Global AI-Designed Small-Molecule Drugs Sales Market Share by Company in 2025
Figure 57. AI-Designed Small-Molecule Drugs Revenue by Company in 2025 ($ millions)
Figure 58. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Company in 2025
Figure 59. Global AI-Designed Small-Molecule Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 60. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Geographic Region in 2025
Figure 61. Americas AI-Designed Small-Molecule Drugs Sales 2021-2026 (K Dose)
Figure 62. Americas AI-Designed Small-Molecule Drugs Revenue 2021-2026 ($ millions)
Figure 63. APAC AI-Designed Small-Molecule Drugs Sales 2021-2026 (K Dose)
Figure 64. APAC AI-Designed Small-Molecule Drugs Revenue 2021-2026 ($ millions)
Figure 65. Europe AI-Designed Small-Molecule Drugs Sales 2021-2026 (K Dose)
Figure 66. Europe AI-Designed Small-Molecule Drugs Revenue 2021-2026 ($ millions)
Figure 67. Middle East & Africa AI-Designed Small-Molecule Drugs Sales 2021-2026 (K Dose)
Figure 68. Middle East & Africa AI-Designed Small-Molecule Drugs Revenue 2021-2026 ($ millions)
Figure 69. Americas AI-Designed Small-Molecule Drugs Sales Market Share by Country in 2025
Figure 70. Americas AI-Designed Small-Molecule Drugs Revenue Market Share by Country (2021-2026)
Figure 71. Americas AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Figure 72. Americas AI-Designed Small-Molecule Drugs Sales Market Share by Application (2021-2026)
Figure 73. United States AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Canada AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Mexico AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Brazil AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. APAC AI-Designed Small-Molecule Drugs Sales Market Share by Region in 2025
Figure 78. APAC AI-Designed Small-Molecule Drugs Revenue Market Share by Region (2021-2026)
Figure 79. APAC AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Figure 80. APAC AI-Designed Small-Molecule Drugs Sales Market Share by Application (2021-2026)
Figure 81. China AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 82. Japan AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 83. South Korea AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 84. Southeast Asia AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 85. India AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 86. Australia AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 87. China Taiwan AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 88. Europe AI-Designed Small-Molecule Drugs Sales Market Share by Country in 2025
Figure 89. Europe AI-Designed Small-Molecule Drugs Revenue Market Share by Country (2021-2026)
Figure 90. Europe AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Figure 91. Europe AI-Designed Small-Molecule Drugs Sales Market Share by Application (2021-2026)
Figure 92. Germany AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 93. France AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 94. UK AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 95. Italy AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 96. Russia AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 97. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Market Share by Country (2021-2026)
Figure 98. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Figure 99. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Market Share by Application (2021-2026)
Figure 100. Egypt AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 101. South Africa AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 102. Israel AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 103. Turkey AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 104. GCC Countries AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 105. Manufacturing Cost Structure Analysis of AI-Designed Small-Molecule Drugs in 2026
Figure 106. Manufacturing Process Analysis of AI-Designed Small-Molecule Drugs
Figure 107. Industry Chain Structure of AI-Designed Small-Molecule Drugs
Figure 108. Channels of Distribution
Figure 109. Global AI-Designed Small-Molecule Drugs Sales Market Forecast by Region (2027-2032)
Figure 110. Global AI-Designed Small-Molecule Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 111. Global AI-Designed Small-Molecule Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 112. Global AI-Designed Small-Molecule Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 113. Global AI-Designed Small-Molecule Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 114. Global AI-Designed Small-Molecule Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of AI-Designed Small-Molecule Drugs
Figure 2. AI-Designed Small-Molecule Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AI-Designed Small-Molecule Drugs Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global AI-Designed Small-Molecule Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. AI-Designed Small-Molecule Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. AI-Designed Small-Molecule Drugs Sales Market Share by Country/Region (2025)
Figure 10. AI-Designed Small-Molecule Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Discovery-Stage Candidates
Figure 12. Product Picture of Preclinical Candidates
Figure 13. Product Picture of Clinical-Stage Candidates
Figure 14. Product Picture of Approved Drugs
Figure 15. Global AI-Designed Small-Molecule Drugs Sales Market Share by Type in 2026
Figure 16. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Enzyme Inhibitors
Figure 18. Product Picture of Receptor Agonists
Figure 19. Product Picture of Receptor Antagonists
Figure 20. Product Picture of Targeted Protein Degraders
Figure 21. Product Picture of Molecular Glues
Figure 22. Product Picture of Other Small-Molecule Modulators
Figure 23. Global AI-Designed Small-Molecule Drugs Sales Market Share by Mechanism of Action in 2026
Figure 24. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Mechanism of Action (2021-2026)
Figure 25. Product Picture of Oral Drugs
Figure 26. Product Picture of Injectable Drugs
Figure 27. Product Picture of Inhaled Drugs
Figure 28. Product Picture of Topical Drugs
Figure 29. Product Picture of Other Administration Routes
Figure 30. Global AI-Designed Small-Molecule Drugs Sales Market Share by Route of Administration in 2026
Figure 31. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Route of Administration (2021-2026)
Figure 32. Product Picture of Kinases
Figure 33. Product Picture of Other Enzymes
Figure 34. Product Picture of G Protein-Coupled Receptors
Figure 35. Product Picture of Nuclear Receptors
Figure 36. Product Picture of Protein–Protein Interaction Targets
Figure 37. Product Picture of Nucleic Acid Targets
Figure 38. Product Picture of Other Target Classes
Figure 39. Global AI-Designed Small-Molecule Drugs Sales Market Share by Target Class in 2026
Figure 40. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Target Class (2021-2026)
Figure 41. AI-Designed Small-Molecule Drugs Consumed in Oncology
Figure 42. Global AI-Designed Small-Molecule Drugs Market: Oncology (2021-2026) & (K Dose)
Figure 43. AI-Designed Small-Molecule Drugs Consumed in Immunology and Inflammation
Figure 44. Global AI-Designed Small-Molecule Drugs Market: Immunology and Inflammation (2021-2026) & (K Dose)
Figure 45. AI-Designed Small-Molecule Drugs Consumed in Neurology and Psychiatry
Figure 46. Global AI-Designed Small-Molecule Drugs Market: Neurology and Psychiatry (2021-2026) & (K Dose)
Figure 47. AI-Designed Small-Molecule Drugs Consumed in Metabolic and Cardiovascular Diseases
Figure 48. Global AI-Designed Small-Molecule Drugs Market: Metabolic and Cardiovascular Diseases (2021-2026) & (K Dose)
Figure 49. AI-Designed Small-Molecule Drugs Consumed in Infectious Diseases
Figure 50. Global AI-Designed Small-Molecule Drugs Market: Infectious Diseases (2021-2026) & (K Dose)
Figure 51. AI-Designed Small-Molecule Drugs Consumed in Other Therapeutic Areas
Figure 52. Global AI-Designed Small-Molecule Drugs Market: Other Therapeutic Areas (2021-2026) & (K Dose)
Figure 53. Global AI-Designed Small-Molecule Drugs Sale Market Share by Application (2025)
Figure 54. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Application in 2025
Figure 55. AI-Designed Small-Molecule Drugs Sales by Company in 2025 (K Dose)
Figure 56. Global AI-Designed Small-Molecule Drugs Sales Market Share by Company in 2025
Figure 57. AI-Designed Small-Molecule Drugs Revenue by Company in 2025 ($ millions)
Figure 58. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Company in 2025
Figure 59. Global AI-Designed Small-Molecule Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 60. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Geographic Region in 2025
Figure 61. Americas AI-Designed Small-Molecule Drugs Sales 2021-2026 (K Dose)
Figure 62. Americas AI-Designed Small-Molecule Drugs Revenue 2021-2026 ($ millions)
Figure 63. APAC AI-Designed Small-Molecule Drugs Sales 2021-2026 (K Dose)
Figure 64. APAC AI-Designed Small-Molecule Drugs Revenue 2021-2026 ($ millions)
Figure 65. Europe AI-Designed Small-Molecule Drugs Sales 2021-2026 (K Dose)
Figure 66. Europe AI-Designed Small-Molecule Drugs Revenue 2021-2026 ($ millions)
Figure 67. Middle East & Africa AI-Designed Small-Molecule Drugs Sales 2021-2026 (K Dose)
Figure 68. Middle East & Africa AI-Designed Small-Molecule Drugs Revenue 2021-2026 ($ millions)
Figure 69. Americas AI-Designed Small-Molecule Drugs Sales Market Share by Country in 2025
Figure 70. Americas AI-Designed Small-Molecule Drugs Revenue Market Share by Country (2021-2026)
Figure 71. Americas AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Figure 72. Americas AI-Designed Small-Molecule Drugs Sales Market Share by Application (2021-2026)
Figure 73. United States AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Canada AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Mexico AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Brazil AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. APAC AI-Designed Small-Molecule Drugs Sales Market Share by Region in 2025
Figure 78. APAC AI-Designed Small-Molecule Drugs Revenue Market Share by Region (2021-2026)
Figure 79. APAC AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Figure 80. APAC AI-Designed Small-Molecule Drugs Sales Market Share by Application (2021-2026)
Figure 81. China AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 82. Japan AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 83. South Korea AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 84. Southeast Asia AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 85. India AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 86. Australia AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 87. China Taiwan AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 88. Europe AI-Designed Small-Molecule Drugs Sales Market Share by Country in 2025
Figure 89. Europe AI-Designed Small-Molecule Drugs Revenue Market Share by Country (2021-2026)
Figure 90. Europe AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Figure 91. Europe AI-Designed Small-Molecule Drugs Sales Market Share by Application (2021-2026)
Figure 92. Germany AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 93. France AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 94. UK AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 95. Italy AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 96. Russia AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 97. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Market Share by Country (2021-2026)
Figure 98. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Market Share by Type (2021-2026)
Figure 99. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Market Share by Application (2021-2026)
Figure 100. Egypt AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 101. South Africa AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 102. Israel AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 103. Turkey AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 104. GCC Countries AI-Designed Small-Molecule Drugs Revenue Growth 2021-2026 ($ millions)
Figure 105. Manufacturing Cost Structure Analysis of AI-Designed Small-Molecule Drugs in 2026
Figure 106. Manufacturing Process Analysis of AI-Designed Small-Molecule Drugs
Figure 107. Industry Chain Structure of AI-Designed Small-Molecule Drugs
Figure 108. Channels of Distribution
Figure 109. Global AI-Designed Small-Molecule Drugs Sales Market Forecast by Region (2027-2032)
Figure 110. Global AI-Designed Small-Molecule Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 111. Global AI-Designed Small-Molecule Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 112. Global AI-Designed Small-Molecule Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 113. Global AI-Designed Small-Molecule Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 114. Global AI-Designed Small-Molecule Drugs Revenue Market Share Forecast by Application (2027-2032)
